- Home
- DXCM vs TROW Comparison
DXCM vs TROW Comparison
Compare DXCM & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- TROW
- Stock Information
- Founded
- DXCM 1999
- TROW 1937
- Country
- DXCM United States
- TROW United States
- Employees
- DXCM N/A
- TROW N/A
- Industry
- DXCM Medical/Dental Instruments
- TROW Investment Bankers/Brokers/Service
- Sector
- DXCM Health Care
- TROW Finance
- Exchange
- DXCM Nasdaq
- TROW Nasdaq
- Market Cap
- DXCM 31.7B
- TROW 23.8B
- IPO Year
- DXCM 2005
- TROW N/A
- Fundamental
- Price
- DXCM $76.55
- TROW $103.69
- Analyst Decision
- DXCM Strong Buy
- TROW Sell
- Analyst Count
- DXCM 19
- TROW 12
- Target Price
- DXCM $99.89
- TROW $102.75
- AVG Volume (30 Days)
- DXCM 4.2M
- TROW 1.5M
- Earning Date
- DXCM 10-23-2025
- TROW 10-31-2025
- Dividend Yield
- DXCM N/A
- TROW 4.89%
- EPS Growth
- DXCM N/A
- TROW 5.45
- EPS
- DXCM 1.43
- TROW 8.93
- Revenue
- DXCM $4,300,800,000.00
- TROW $7,097,300,000.00
- Revenue This Year
- DXCM $17.03
- TROW $4.01
- Revenue Next Year
- DXCM $15.59
- TROW $4.96
- P/E Ratio
- DXCM $53.53
- TROW $11.61
- Revenue Growth
- DXCM 9.30
- TROW 4.43
- 52 Week Low
- DXCM $57.52
- TROW $77.85
- 52 Week High
- DXCM $93.25
- TROW $125.81
- Technical
- Relative Strength Index (RSI)
- DXCM 44.48
- TROW 42.43
- Support Level
- DXCM $75.39
- TROW $104.60
- Resistance Level
- DXCM $78.96
- TROW $118.22
- Average True Range (ATR)
- DXCM 2.36
- TROW 2.28
- MACD
- DXCM -0.01
- TROW -0.63
- Stochastic Oscillator
- DXCM 37.70
- TROW 2.74
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About TROW T. Rowe Price Group Inc.
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of July 2025, the firm had $1.703 trillion in managed assets, composed of equity (50%), balanced (35%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.